Oncovir
Business Services · District of Columbia, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3203 Cleveland Ave NW, Washington, Distr...Phone Number
(202) 342-1726Website
www.oncovir.comRevenue
<$5 MillionIndustry
About Oncovir
Oncovir, Inc. is a Clinical Phase Biotechnology company focused on developing Hiltonol (Poly ICLC) as a drug product and vaccine adjuvant for oncology and infectious diseases. The company aims to activate both innate and adaptive immunity to enhance treatment outcomes. Their innovative approach includes combining poly-ICLC with immunotherapy vaccines, particularly for challenging conditions like brain cancer. Oncovir targets healthcare providers and researchers in the fields of cancer and infectious disease treatment.Explore more
Oncovir Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Oncovir
Compare insights from companies similar to Oncovir, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Oncovir Tech Stack
A closer look at the technologies used by Oncovir
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Oncovir
Sign Up For FreeTo access detailed company insights
Oncovir, Inc. is a Clinical Phase Biotechnology company focused on developing Hiltonol (Poly ICLC) as a drug product and vaccine adjuvant for oncology and infectious diseases. The company aims to activate both innate and adaptive immunity to enhance treatment outcomes. Their innovative approach includes combining poly-ICLC with immunotherapy vaccin... Read More
